◼ Archived
Business
🔮 fades ✗
11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy
GLP-1 weight loss drugs are being used by a record number of Americans.
Obesity
6 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Health
🔮 fades ✓
About 170,000 people in England expected to die from obesity-linked heart conditions by 2035
New research warns of a grim future for England's heart health due to rising obesity rates
◼ Archived
Health
🔮 fades ✓
The negative impacts of fruit juices and other sugary treats for children
Recent studies highlight the long-term health risks of sugary beverages for children.
◼ Archived
Health
🔮 fades ✓
Research shows weight-loss drugs may also reduce cancer risk
New research indicates GLP-1 receptor agonists used for weight loss may be linked to a reduced risk of certain cancers, specifically breast cancer.
◼ Archived
Health
🔮 fades ✓
The "dad bod," explained by science
Recent scientific analysis examines the 'dad bod' and how paternal obesity and diet impact the long-term health of children.
◼ Archived
Health
🔮 fades ✓
Ozempic users may be making a major weight-loss mistake, new study suggests
New research indicates a trend of decreased physical activity among individuals using GLP-1 weight loss medications like Ozempic and Wegovy.